NUDT1 and cancer: The significance of MTH1 as a target for cancer treatment was questioned by several recent reports, in part by the fact that knockdowns of MTH1 by RNA interference (RNAi) or CRISPR technology failed to mirror the effects that were observed with the inhibitors [12–14].